10-Q: PureCycle Secures $300M, Eyes Global Expansion & Profitability

PureCycle Technologies reports first meaningful revenues and a significant capital raise, alleviating near-term going concern doubts while outlining ambitious global expansion plans.

Summary

• PureCycle Technologies reported $5.66 million in revenues for the nine months ended September 30, 2025, marking its first year of meaningful operations.
• The net loss for the nine months ended September 30, 2025, significantly improved to $163.78 million, compared to $224.46 million in the prior year.
• The company successfully raised approximately $300.0 million in gross proceeds from a private placement of Series B Convertible Perpetual Preferred Stock in June 2025, which alleviated immediate going concern doubts.
• Strategic plans include constructing a 130.0 million pound polypropylene recycling facility in Thailand (operational 2027), another 130.0 million pound facility in Antwerp, Belgium (operational 2028), and a 300.0 million pound multi-line purification facility in Augusta, Georgia (first line operational 2029).
• Additional FDA Letters of No Objection (LNOs) were received, expanding the use of PureFive resin in food contact applications under broader process conditions.
• Operating costs increased by $22.46 million for the nine months ended September 30, 2025, primarily due to production ramp-up at the Ironton Facility and preliminary planning for new facilities.
• Legal costs decreased by $7.5 million for the nine months ended September 30, 2025, mainly due to the settlement of outstanding cases.
• The Revolving Credit Facility maturity date was extended from September 30, 2026, to September 30, 2027.
• The arbitration hearing for the Denham-Blythe dispute concluded in August 2025, with the parties awaiting a decision.

Sentiment

Score: 7

Explanation: The company successfully addressed its immediate going concern doubt with a substantial capital raise and reported its first meaningful revenues. The reduction in net loss and clear strategic plans for global expansion and product commercialization indicate positive momentum. However, significant operational ramp-up and construction risks remain, and the company is still operating at a loss.

Positives

• Successfully raised $300.0 million in gross proceeds from the Series B Convertible Perpetual Preferred Stock offering, alleviating going concern doubt for at least the next twelve months.
• Reported $5.66 million in revenue for the nine months ended September 30, 2025, marking the first year of meaningful operations.
• Net loss significantly reduced to $163.78 million for the nine months ended September 30, 2025, an improvement from $224.46 million in the prior year.
• Strong cash position with $234.36 million in cash and cash equivalents as of September 30, 2025, a substantial increase from $15.68 million at December 31, 2024.
• Announced ambitious global expansion plans for new facilities in Thailand (130M lbs/year, 2027), Antwerp (130M lbs/year, 2028), and Augusta (300M lbs/year, 2029).
• Received additional FDA LNOs, broadening PureFive resin's applicability for food contact uses and allowing for greater processing flexibility and reduced energy usage.
• Legal costs decreased by $7.5 million for the nine months ended September 30, 2025, primarily due to the settlement of outstanding cases.
• The Revolving Credit Facility maturity was extended to September 30, 2027, providing longer-term liquidity access.

Negatives

• Operating loss increased to $122.25 million for the nine months ended September 30, 2025, from $110.20 million in the prior year.
• Cost of operations increased by $22.46 million for the nine months ended September 30, 2025, driven by production ramp-up, professional services for new facilities, and expanded facilities costs.
• Interest expense increased by $7.26 million for the nine months ended September 30, 2025, primarily due to interest on Series A Preferred Stock and higher Revenue Bonds.
• Total stockholders' equity decreased significantly to $68.22 million from $180.45 million, largely due to the reclassification of Series B Preferred Stock to mezzanine equity.
• The current portion of warrant liability increased substantially to $60.24 million from $10.11 million, indicating near-term obligations.
• The Ironton Facility is still undergoing commissioning activities and is not yet operating at expected full capacity.
• Potential non-cash charge for loss on disposition of equipment if previously purchased Augusta equipment cannot be repurposed for other facilities or redesigned Augusta facility.

Risks

• Ability to obtain funding for operations and future growth and to continue as a going concern longer term, dependent on continued improvement at the Ironton Facility, commercialization of PureFive resin, and successful construction/sales from Thailand and Antwerp facilities.
• Ability to meet, and continue to meet, applicable regulatory requirements for the use of PureFive resin in food grade applications in various international locations.
• Ability to comply on an ongoing basis with numerous regulatory requirements applicable to PureFive resin and facilities.
• Ability of the Ironton Facility to commence full-scale commercial operations in a timely and cost-effective manner, or at all.
• Ability to complete the necessary funding with respect to, and complete the construction of, new polypropylene recycling facilities in Thailand, Antwerp, Belgium, and Augusta, Georgia, in a timely and cost-effective manner.
• Ability to execute the growth plan to bring an additional one billion pounds of installed polypropylene recycling capability online before 2030, including meeting related construction, regulatory, and financing requirements.
• Ability to procure, sort, and process polypropylene plastic waste at planned Feed PreP facilities.
• Ability to maintain exclusivity under The Procter & Gamble Company (P&G) license.
• Success or profitability of offtake arrangements.
• Potential impact of economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs).
• Changes in the prices and availability of materials (e.g., steel) and labor, including those caused by inflation, tariffs, and supply chain conditions.
• Ability to source feedstock with a high polypropylene content at a reasonable cost.
• Outcome of any legal or regulatory proceedings to which the company is, or may become, a party.
• Business disruptions due to political or economic instability, pandemics, or armed hostilities.

Future Outlook

The company expects revenue growth in future periods from ongoing customer application trials. Operating costs and selling, general, and administrative expenses are anticipated to increase as operations scale and headcount grows. The company intends to re-direct and re-purpose certain previously purchased long-lead equipment, valued at $195 million, for its projects in Antwerp, Belgium, and/or Rayong, Thailand, and plans to design a larger capacity facility, with the first to be constructed at Augusta, Georgia. Additional funds, significantly exceeding the remaining unallocated Green Convertible Notes proceeds, will be used for Augusta engineering design and long-lead items. The company's longer-term ability to continue as a going concern is dependent on continued improvement in operations at the Ironton Facility, commercialization of its PureFive resin product, and the successful construction and sale of product from its future Thailand and Antwerp facilities. Management continues to evaluate different strategies and may pursue additional actions to further increase its liquidity position.

Management Comments

• The going concern conclusion as previously disclosed in the March 31, 2025, Form 10-Q is no longer applicable for at least the twelve-month period from the issuance date of these financial statements.
• The improvement in the Company's financial condition is attributable to the Company raising proceeds from the sale of the Series B Convertible Perpetual Preferred Stock.
• The Company's current financial projections support the Company's ability to meet its obligations as they become due for at least one year from the issuance of these financial statements.
• The Company's ability to continue as a going concern longer term is dependent on continued improvement in operations at the Ironton Facility, the commercialization of its PureFive resin product, and the successful construction and sale of product from its future Thailand and Antwerp facilities.
• Management continues to evaluate different strategies and may pursue additional actions to further increase its liquidity position.
• We expect our operating costs to increase as we continue to scale operations and increase headcount.
• We expect our selling, general, and administrative expenses to increase for the foreseeable future as we scale headcount with the growth of our business.
• Currently, we are in the early stages of the planning and design of our Thailand, Belgium and Augusta facilities, so we are not yet able to determine the loss, if any, for equipment that may not be placed into operation.
• Our management, with the participation of our principal executive and financial officers, has evaluated the effectiveness of our disclosure controls and procedures and has concluded that such disclosure controls and procedures were effective as of September 30, 2025.

Industry Context

PureCycle Technologies operates in the rapidly evolving polypropylene recycling market, aiming to address the global demand for sustainable plastic solutions. Its patented technology for restoring waste polypropylene into near-virgin PureFive resin positions it to assist multinational corporations in achieving sustainability goals and complying with federal and state regulations. The receipt of additional FDA LNOs is critical for expanding market acceptance, particularly in the food packaging sector, aligning with broader industry trends towards circular economy adapted products and increased use of recycled content. The company's global expansion strategy into Thailand and Belgium indicates an intent to capture international demand and leverage existing industrial infrastructure to reduce costs, reflecting a competitive approach in a growing but challenging market.

Comparison to Industry Standards

• The filing does not provide specific industry benchmarks or comparable company data to assess PureCycle Technologies' performance against global industry standards, competitors, or specific projects. The analysis focuses on internal operational and financial metrics.

Management Changes

Corporate Governance

Legal Proceedings

• **Denham-Blythe Arbitration:** Denham-Blythe Company, Inc. (DB) filed a demand for binding arbitration on June 16, 2023, seeking approximately $17.0 million plus attorney's fees and costs related to construction activities at the Ironton Facility. PCO filed a counterclaim alleging damages in excess of $17.0 million due to deficiencies in DB's work. The arbitration hearing concluded in August 2025, and the parties await the decision of the arbitration panel.
• **ISC Constructors Lawsuit:** ISC Constructors, a DB subcontractor, filed an action in equity for unjust enrichment against PCO in Lawrence Co. Ohio, alleging $0.5 million in unpaid invoices and retainage. This lawsuit was consolidated with the pending DB claims and stayed pending completion of the arbitration. ISC also filed an arbitration claim against DB for the same amount, which has been separated for a later hearing.
• **Piot v. Bouck, et al. (Derivative Action):** A purported shareholder, Selim Piot, initiated a derivative action on May 6, 2024, in the Chancery Court of Delaware. The claims were substantially similar to previously resolved derivative lawsuits. The action was dismissed with prejudice on July 23, 2025, following a stipulation by the parties.

Related Party Transactions

• Purchased $0.8 million of certain chemicals from Milliken & Company during the nine months ended September 30, 2025.
• Maintained a $200.0 million Revolving Credit Facility with Sylebra Capital Management (a greater than 5% beneficial owner), with its maturity extended to September 30, 2027. The company borrowed and repaid $10.0 million from this facility in June 2025.
• Executed a 30-day promissory note with Pure Plastic LLC for $4.9 million in June 2025, which was repaid with $0.02 million in accrued interest.
• Sold $11.4 million in aggregate principal amount of Senior Bonds to related parties for gross proceeds of $10.1 million during the nine months ended September 30, 2025.
• Investment entities affiliated with Sylebra, Samlyn Capital, LLC, Pure Crown LLC, and Daniel Gibson participated in the private placement of Series B Convertible Perpetual Preferred Stock, contributing to the $300.0 million gross proceeds.
• Issued 4,003 shares of Series A Preferred Stock for in-kind dividend payments during the three and nine months ended September 30, 2025, with 2,001 shares issued to Sylebra and 2,002 shares to Samlyn.
• Glockner Family Venture Fund LP (a related party) exercised 0.1 million Series A Warrants on July 28, 2025, resulting in $1.2 million cash received and 0.1 million common shares issued.
• Affiliates of Sylebra and Samlyn purchased 524,349 shares of Common Stock for approximately $4.2 million in a private placement on February 5, 2025.

Stakeholder Impact

• **Shareholders:** The significant capital raise through Series B Preferred Stock issuance, while alleviating going concern risk, introduces a new class of preferred equity with senior dividend and liquidation rights, potentially diluting common shareholders' claims. The reduction in net loss and first meaningful revenues are positive for shareholder confidence, but ongoing operational losses and future capital needs remain.
• **Employees:** Increased employee-related costs and headcount growth are expected as the company scales operations, indicating potential job creation and stability. Equity-based compensation continues to be a component of employee remuneration.
• **Customers:** The expansion of FDA LNOs for PureFive resin broadens its applicability in food contact products, offering customers more sustainable material options. The planned global facilities aim to increase supply and meet growing demand for recycled polypropylene.
• **Creditors:** The $300.0 million capital raise and extension of the Revolving Credit Facility maturity improve the company's liquidity and ability to meet obligations, reducing immediate credit risk. However, increased long-term debt and related party bonds payable indicate continued reliance on debt financing.
• **Suppliers:** Increased production at the Ironton Facility and planning for new facilities will likely lead to increased demand for feedstock and other operational supplies, potentially benefiting suppliers. The company's ability to source feedstock at a reasonable cost is crucial for its operations.

Next Steps

• Continue improving operations at the Ironton Facility.
• Commercialize the PureFive resin product.
• Successfully construct and sell product from future Thailand and Antwerp facilities.
• Evaluate different strategies to further increase liquidity.
• Continue the permitting process for the Thailand facility, with expected operational status in 2027.
• Advance the permitting process in Belgium, with all permits expected to be submitted by the end of 2025, and the facility projected operational in 2028.
• Construct a 300.0 million pound multi-line purification facility at Augusta, Georgia, with the first line expected operational in 2029.
• Conduct additional testing and plan further FDA LNO submissions for additional post-consumer recycled feedstock sources and expanded Conditions of Use (COUs).
• Await the arbitration panel decision for the Denham-Blythe Arbitration.
• Potentially redeem Series A Preferred Stock by March 17, 2026, if sufficient proceeds from Series A Warrants exercise and Board approval are obtained.
• Adopt ASU 2023-09 for the annual period ending December 31, 2025, to include expanded income tax disclosures.

Key Dates

Recommendation

The company has made significant strides in improving its liquidity and addressing going concern doubts through a substantial capital raise. The reduction in net loss and the initiation of meaningful revenues are positive indicators. Strategic plans for global expansion and continued FDA clearances for its PureFive resin demonstrate a clear path for future growth. However, the company is still in the early stages of commercialization and faces considerable operational risks, including the ramp-up of the Ironton Facility and the successful construction and funding of new facilities. The increased operating costs and interest expenses highlight the ongoing financial demands. A 'hold' recommendation reflects the positive developments and long-term potential, balanced against the inherent execution risks and the fact that the company is still operating at a loss. Investors should monitor progress on facility operations, commercialization, and capital management closely.

Keywords

PureCycle Technologies, Polypropylene recycling, PureFive resin, SEC filing, 10-Q, Financial results, Capital raise, Ironton Facility, Augusta Facility, Thailand facility, Antwerp facility, FDA LNO, Green Convertible Notes, Series B Preferred Stock, Warrants, Sustainability, Circular economy, Waste management, Plastics recycling